Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 132.40

-0.7%

Jan 16 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DewDiligence_on_SI who wrote (1373)	2/18/2005 10:26:52 AM
From: rkrw	Read Replies (1) of 1834

<<That’s utter nonsense.>> There's been several products recently where the bio has given up on profit sharing and restructured into royalty bearing. They couldn't afford the losses any longer. By the time they restructured they weren't exactly in positions of strength to negotiate much better than piddly royalties. If you think the icos deal was equivalent to nbix's then you should be buying the hell out of icos right now imo. icos would have earned $190M in straight royalties last year under nbix terms.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next